BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25672416)

  • 1. CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinoma.
    Takano N; Hishida M; Inokawa Y; Hayashi M; Kanda M; Nishikawa Y; Iwata N; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y; Nomoto S
    Int J Oncol; 2015 May; 46(5):1963-70. PubMed ID: 25672416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis.
    Inokawa Y; Nomoto S; Hishida M; Hayashi M; Kanda M; Nishikawa Y; Takeda S; Sugimoto H; Fujii T; Yamada S; Kodera Y
    J Exp Clin Cancer Res; 2013 Sep; 32(1):65. PubMed ID: 24034596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine kinase 7: a hepatocellular carcinoma-related gene detected by triple-combination array.
    Hishida M; Inokawa Y; Takano N; Nishikawa Y; Iwata N; Kanda M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y; Nomoto S
    J Surg Res; 2015 May; 195(2):444-53. PubMed ID: 25796105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis.
    Hishida M; Nomoto S; Inokawa Y; Hayashi M; Kanda M; Okamura Y; Nishikawa Y; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Takeda S; Kodera Y
    Int J Oncol; 2013 Jul; 43(1):88-94. PubMed ID: 23695389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.
    Kanda M; Nomoto S; Okamura Y; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Int J Oncol; 2009 Sep; 35(3):477-83. PubMed ID: 19639168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis.
    Inokawa Y; Nomoto S; Hishida M; Hayashi M; Kanda M; Nishikawa Y; Takeda S; Fujiwara M; Koike M; Sugimoto H; Fujii T; Nakayama G; Yamada S; Tanaka C; Kobayashi D; Kodera Y
    Onco Targets Ther; 2013; 6():1417-24. PubMed ID: 24143113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
    J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma.
    Kanda M; Nomoto S; Okamura Y; Hayashi M; Hishida M; Fujii T; Nishikawa Y; Sugimoto H; Takeda S; Nakao A
    Mol Carcinog; 2011 Aug; 50(8):571-9. PubMed ID: 21268132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma.
    Hayashi M; Nomoto S; Hishida M; Inokawa Y; Kanda M; Okamura Y; Nishikawa Y; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Takeda S; Kodera Y
    BMC Cancer; 2014 Feb; 14():108. PubMed ID: 24552139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
    Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
    Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
    Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.